Pharmacyclics Inc (PCYC) financial statements (2020 and earlier)

Company profile

Business Address PHARMACYCLICS INC
SUNNYVALE, CA 94085-4521
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments857636317
Cash and cash equivalents845624307
Short-term investments121210
Receivables641127
Inventory, net of allowances, customer advances and progress billings3413
Inventory3413 
Prepaid expense and other current assets3
Other undisclosed current assets6082 
Total current assets:1,016741346
Noncurrent Assets
Property, plant and equipment32256
Intangible assets, net (including goodwill)9
Intangible assets, net (excluding goodwill)9  
Other noncurrent assets32
Prepaid expense and other noncurrent assets2
Total noncurrent assets:45289
TOTAL ASSETS:1,060769355
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1158021
Accounts payable745
Accrued liabilities887515
Employee-related liabilities20  
Taxes payable011
Deferred revenue and credits1988
Other undisclosed current liabilities60  
Total current liabilities:1948829
Noncurrent Liabilities
Liabilities, other than long-term debt375363
Deferred revenue and credits355263
Other liabilities21 
Total noncurrent liabilities:375363
Total liabilities:23114193
Stockholders' equity
Stockholders' equity attributable to parent829628263
Common stock000
Additional paid in capital960844546
Accumulated other comprehensive loss(0)(0)(0)
Accumulated deficit(130)(217)(284)
Total stockholders' equity:829628263
TOTAL LIABILITIES AND EQUITY:1,060769355

Income statement (P&L) ($ in millions)

12/31/2014
12/31/2013
12/31/2012
Revenues730260 
Revenue, net49214 
Cost of revenue(263)  
Cost of goods and services sold(40)  
Gross profit:467260 
Operating expenses(345)(192) 
Other undisclosed operating income 29 
Operating income:12298 
Nonoperating expense
(Other Nonoperating expense)
(0)(0) 
Other undisclosed income from continuing operations before equity method investments, income taxes00 
Income from continuing operations before income taxes:12298 
Income tax expense(36)(31) 
Net income available to common stockholders, diluted:8667 

Comprehensive Income ($ in millions)

12/31/2014
12/31/2013
12/31/2012
Net income:8667 
Comprehensive income:8667 
Other undisclosed comprehensive loss, net of tax, attributable to parent (0) 
Comprehensive income, net of tax, attributable to parent:8667 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: